CRNX

42.85

1.49% -0.65

Handel nachbörslich: 42.85

Crinetics Pharmaceuticals Inc (CRNX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CRNX? Forum Prognose

Schlusskurs vom Vortag:

$43.50

Offen:

$43.3

24-Stunden-Volumen:

1.22M

Relative Volume:

0.83

Marktkapitalisierung:

$4.04B

Einnahmen:

$4.72M

Nettoeinkommen (Verlust:

$-277.91M

KGV:

-11.49

EPS:

-3.73

Netto-Cashflow:

$-203.56M

1W Leistung:

-3.36%

1M Leistung:

+4.87%

6M Leistung:

+26.93%

1J Leistung:

-24.41%

1-Tages-Spanne:

$42.05

$43.34

1-Wochen-Bereich:

$41.12

$44.70

52-Wochen-Spanne:

$24.10

$62.53

Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile

Firmenname

Crinetics Pharmaceuticals Inc

Sektor

Healthcare (1136)

Branche

Biotechnology (633)

Telefon

858-450-6464

Adresse

6055 LUSK BLVD., SAN DIEGO, CA

Mitarbeiter

437

Twitter

@Crinetics

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

CRNX's Discussions on Twitter

Vergleichen Sie CRNX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CRNX Crinetics Pharmaceuticals Inc	42.85	4.10B	4.72M	-277.91M	-203.56M	-3.73
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-10	Eingeleitet	Goldman	Neutral
2025-03-25	Eingeleitet	Stifel	Buy
2025-02-11	Eingeleitet	TD Cowen	Buy
2025-02-04	Eingeleitet	Wolfe Research	Peer Perform
2025-01-22	Hochstufung	Jefferies	Hold → Buy
2024-03-06	Eingeleitet	Citigroup	Buy
2024-01-16	Eingeleitet	Morgan Stanley	Overweight
2023-12-21	Eingeleitet	Jefferies	Hold
2023-11-20	Fortgesetzt	JP Morgan	Overweight
2023-10-24	Fortgesetzt	Cantor Fitzgerald	Overweight
2023-08-31	Eingeleitet	Oppenheimer	Outperform
2023-04-24	Eingeleitet	Piper Sandler	Overweight
2023-03-30	Eingeleitet	Robert W. Baird	Outperform
2021-11-30	Eingeleitet	JMP Securities	Mkt Outperform
2021-11-23	Eingeleitet	Evercore ISI	Outperform
2021-06-18	Hochstufung	JP Morgan	Neutral → Overweight
2019-12-23	Eingeleitet	ROTH Capital	Buy
2019-02-14	Eingeleitet	H.C. Wainwright	Buy
2018-08-13	Eingeleitet	JP Morgan	Neutral
2018-08-13	Eingeleitet	Leerink Partners	Outperform
2018-08-13	Eingeleitet	Piper Jaffray	Overweight

Alle ansehen

Crinetics Pharmaceuticals Inc Aktie (CRNX) Neueste Nachrichten

Nov 03, 2025

Quantitative breakdown of Crinetics Pharmaceuticals Inc. recent moveWeekly Investment Report & Free Risk Controlled Daily Trade Plans - newser.com

Nov 03, 2025

Will Crinetics Pharmaceuticals Inc. benefit from macro trendsJuly 2025 Price Swings & Verified Entry Point Signals - newser.com

Nov 03, 2025

How interest rate cuts could boost Crinetics Pharmaceuticals Inc. stockJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com

Nov 03, 2025

Why Crinetics Pharmaceuticals Inc. (6Z4) stock attracts HNW investorsWeekly Trend Report & Safe Swing Trade Setups - newser.com

Nov 03, 2025

Analyzing recovery setups for Crinetics Pharmaceuticals Inc. investors2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com

Nov 03, 2025

What institutional flow reveals about Crinetics Pharmaceuticals Inc.July 2025 Market Mood & Momentum Based Trading Ideas - newser.com

Nov 03, 2025

Top chart patterns to watch in Crinetics Pharmaceuticals Inc.2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com

Nov 03, 2025

Crinetics Pharmaceuticals Inc. stock trend outlook and recovery path2025 Trading Recap & Free Daily Entry Point Trade Alerts - newser.com

Nov 03, 2025

Backtesting results for Crinetics Pharmaceuticals Inc. trading strategiesPortfolio Return Report & Low Risk High Win Rate Picks - newser.com

Nov 03, 2025

Can Crinetics Pharmaceuticals Inc. rally from current levelsTrade Signal Summary & Real-Time Stock Price Movement Reports - newser.com

Nov 03, 2025

Chart based analysis of Crinetics Pharmaceuticals Inc. trendsJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - newser.com

Nov 03, 2025

Identifying reversal signals in Crinetics Pharmaceuticals Inc.2025 Performance Recap & Growth-Oriented Investment Plans - newser.com

Nov 03, 2025

Is Crinetics Pharmaceuticals Inc. stock entering bullish territoryGDP Growth & Verified High Yield Trade Plans - newser.com

Nov 03, 2025

Nov 02, 2025

Sector ETF performance correlation with Crinetics Pharmaceuticals Inc.2025 Historical Comparison & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 02, 2025

Why Crinetics Pharmaceuticals Inc. is moving today2025 Key Lessons & Long-Term Capital Growth Strategies - newser.com

Nov 02, 2025

Using data tools to time your Crinetics Pharmaceuticals Inc. exit2025 Analyst Calls & Smart Allocation Stock Reports - newser.com

Nov 02, 2025

Can Crinetics Pharmaceuticals Inc. (6Z4) stock deliver double digit returnsMarket Volume Report & Low Drawdown Momentum Trade Ideas - newser.com

Nov 02, 2025

Pier Capital LLC Boosts Stock Position in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat

Nov 02, 2025